XML 23 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Intangible Assets and Goodwill
3 Months Ended
Mar. 31, 2012
Intangible Assets and Goodwill  
Intangible Assets and Goodwill

 

(6)  Intangible Assets and Goodwill

 

Intangible assets, net of accumulated amortization, and goodwill are as follows:

 

 

 

 

 

March 31, 2012

 

December 31, 2011

 

 

 

Estimated
Life

 

Cost

 

Accumulated
Amortization

 

Net

 

Cost

 

Accumulated
Amortization

 

Net

 

 

 

 

 

(In thousands)

 

Intangible Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IPR&D

 

Indefinite

 

$

11,800

 

 

$

11,800

 

$

11,800

 

 

$

11,800

 

Amgen Amendment

 

16 years

 

14,500

 

$

(2,242

)

12,258

 

14,500

 

$

(2,018

)

12,482

 

Core Technology

 

4.5 - 11 years

 

1,948

 

(1,374

)

574

 

1,948

 

(1,307

)

641

 

Total Intangible Assets

 

 

 

$

28,248

 

$

(3,616

)

$

24,632

 

$

28,248

 

$

(3,325

)

$

24,923

 

Goodwill

 

Indefinite

 

$

8,965

 

 

$

8,965

 

$

8,965

 

 

$

8,965

 

 

The IPR&D and Amgen Amendment intangible assets relate to the CDX-011 program and were acquired in connection with the Company’s acquisition of CuraGen Corporation in 2009.  The Core Technology intangible asset primarily relates to the rindopepimut program and was acquired in connection with the Company’s acquisition of Alteris Therapeutics, Inc. in 2005.